Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood–Brain Barrier
Drugs in R&D · 2026-03 · 26 (1) · 1-30
DOI: 10.1007/s40268-026-00538-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drugs in R&D, online erschienen am 01.03.2026. Verfasst von Yicong Lei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key laboratory for Advanced Drug Delivery Systems of Guangdong Province, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Tumor Microenvironment, Drug Delivery Systems, Antineoplastic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 373 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Therapeutic efficacy for malignancies and neurological disorders is fundamentally restricted by biological barriers, particularly the complex tumor microenvironment (TME) and selective blood-brain barrier (BBB). This review analyzes advanced drug delivery technologies engineered to overcome these obstacles. For TME penetration, stimuli-responsive nanocarriers enable spatiotemporally controlled drug release, while tumor-penetrating peptide functionalized nanoparticles enhance deep tumor diffusion; metal-organic frameworks further facilitate combinatorial therapy via microenvironment-triggered payload release. Regarding BBB transcendence, receptor-mediated transcytosis strategies significantly improve brain uptake, and physical-assisted approaches achieve localized barrier modulation. Bioinspired platforms-notably cell-membrane-coated nanoparticles and exosomes-demonstrate superior immune evasion and tissue-specific accumulation. Despite promising clinical progress exemplified by ANG1005 and focused ultrasound-assisted liposomal doxorubicin, translation challenges persist, including TME heterogeneity, scalable manufacturing complexities, and long-term biosafety. Future development prioritizes multifunctional theranostic systems integrating barrier-remodeling agents, artificial intelligence (AI)-optimized nanocarrier design, and sustainable manufacturing processes. Collectively, these innovations are transforming advanced drug delivery into a core therapeutic paradigm for intractable diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key laboratory for Advanced Drug Delivery Systems of Guangdong Province, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
- Key laboratory for Advanced Drug Delivery Systems of Guangdong Province, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China. professor_huaqing@126.com.
Zitieren
APA
Lei, Y., Xiao, T., Hu, X., & Lin, H. (2026). Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood–Brain Barrier. Drugs in R&D, 26(1), 1-30. https://doi.org/10.1007/s40268-026-00538-9
Vancouver
Lei Y, Xiao T, Hu X, Lin H. Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood–Brain Barrier. Drugs in R&D. 2026;26(1):1-30. doi:10.1007/s40268-026-00538-9
BibTeX
@article{Lei2026,
author = {Lei, Yicong and Xiao, Tingyu and Hu, Xin and Lin, Huaqing},
title = {Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood–Brain Barrier},
journal = {Drugs in R&D},
year = {2026},
volume = {26},
number = {1},
pages = {1--30},
doi = {10.1007/s40268-026-00538-9}
}
EUVIMED